"","Cites","Authors","Title","Year","Source","Publisher","ArticleURL","CitesURL","GSRank","QueryDate","Type","DOI","ISSN","CitationURL","Volume","Issue","StartPage","EndPage","ECC","CitesPerYear","CitesPerAuthor","AuthorCount","Age","Abstract","generic_drug_name"
"1",0,"J.J. Cragg","Beneficial “Pharmaceutical Pleiotropy” of Gabapentinoids in Spinal Cord Injury: A Case for Refining Standard-of-Care",2020,"Neurorehabilitation and Neural Repair",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086331045&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85086331045&origin=inward",19,"2021-01-15 16:55:13","Article","10.1177/1545968320931516","1545-9683","https://api.elsevier.com/content/abstract/scopus_id/85086331045",34,8,686,689,0,0,0,1,1,NA,"pregabalin"
"2",1,"J. Siedenburg","Transcranial magnetic motor evoked potentials and magnetic resonance imaging findings in paraplegic dogs with recovery of motor function",2018,"Journal of Veterinary Internal Medicine",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85044300630&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85044300630&origin=inward",17,"2021-01-15 16:55:13","Article","10.1111/jvim.15058","0891-6640","https://api.elsevier.com/content/abstract/scopus_id/85044300630",32,3,1116,1125,1,0.33,1,1,3,NA,"pregabalin"
"3",1,"M. Hamdaoui","Restless legs syndrome related to hemorrhage of a thoracic spinal cord cavernoma",2018,"Journal of Spinal Cord Medicine",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85029461192&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85029461192&origin=inward",18,"2021-01-15 16:55:13","Article","10.1080/10790268.2017.1368963","1079-0268","https://api.elsevier.com/content/abstract/scopus_id/85029461192",41,2,245,247,1,0.33,1,1,3,NA,"pregabalin"
"4",2,"S. Moriya","Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion",2017,"Journal of Neurosurgical Sciences",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85026315745&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85026315745&origin=inward",16,"2021-01-15 16:55:13","Article","10.23736/S0390-5616.16.03263-X","0390-5616","https://api.elsevier.com/content/abstract/scopus_id/85026315745",61,5,495,503,2,0.5,2,1,4,NA,"pregabalin"
"5",3,"D. Tang","Therapeutic antibodies for spinal cord injury",2017,"CNS and Neurological Disorders - Drug Targets",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85011044823&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85011044823&origin=inward",15,"2021-01-15 16:55:13","Review","10.2174/1871527315666160915150754","1871-5273","https://api.elsevier.com/content/abstract/scopus_id/85011044823",16,1,51,64,3,0.75,3,1,4,NA,"pregabalin"
"6",4,"C.B. Liu","Dynamic correlation of diffusion tensor imaging and neurological function scores in beagles with spinal cord injury",2018,"Neural Regeneration Research",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048124834&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85048124834&origin=inward",14,"2021-01-15 16:55:13","Article","10.4103/1673-5374.232485","1673-5374","https://api.elsevier.com/content/abstract/scopus_id/85048124834",13,5,877,886,4,1.33,4,1,3,NA,"pregabalin"
"7",5,"Z. Asan","Spinal Cord Injury without Radiological Abnormality in Adults: Clinical and Radiological Discordance",2018,"World Neurosurgery",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045887000&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85045887000&origin=inward",12,"2021-01-15 16:55:13","Article","10.1016/j.wneu.2018.03.162","1878-8750","https://api.elsevier.com/content/abstract/scopus_id/85045887000",114,NA,NA,NA,5,1.67,5,1,3,NA,"pregabalin"
"8",5,"B. Kazanci","Neuroprotective effects of pregabalin against spinal cord ischemia-reperfusion injury in rats",2017,"Turkish Neurosurgery",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85032578111&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85032578111&origin=inward",13,"2021-01-15 16:55:13","Article","10.5137/1019-5149.JTN.17959-16.1","1019-5149","https://api.elsevier.com/content/abstract/scopus_id/85032578111",27,6,952,961,5,1.25,5,1,4,NA,"pregabalin"
"9",8,"J.M. Griffin","Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem",2020,"EMBO Molecular Medicine",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85081108947&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85081108947&origin=inward",10,"2021-01-15 16:55:13","Review","10.15252/emmm.201911505","1757-4676","https://api.elsevier.com/content/abstract/scopus_id/85081108947",12,3,NA,NA,8,8,8,1,1,NA,"pregabalin"
"10",8,"K. Potter-Baker","Reliability of TMS metrics in patients with chronic incomplete spinal cord injury",2016,"Spinal Cord",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962090359&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84962090359&origin=inward",11,"2021-01-15 16:55:13","Article","10.1038/sc.2016.47","1362-4393","https://api.elsevier.com/content/abstract/scopus_id/84962090359",54,11,980,990,8,1.6,8,1,5,NA,"pregabalin"
"11",18,"J.J. Cragg","Effects of pain and pain management on motor recovery of spinal cord-injured patients: A longitudinal study",2016,"Neurorehabilitation and Neural Repair",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981346593&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84981346593&origin=inward",8,"2021-01-15 16:55:13","Article","10.1177/1545968315624777","1545-9683","https://api.elsevier.com/content/abstract/scopus_id/84981346593",30,8,753,761,18,3.6,18,1,5,NA,"pregabalin"
"12",18,"S. Karadimas","The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy",2010,"Current Medicinal Chemistry",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77950671897&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=77950671897&origin=inward",9,"2021-01-15 16:55:13","Review","10.2174/092986710790820598","0929-8673","https://api.elsevier.com/content/abstract/scopus_id/77950671897",17,11,1048,1058,18,1.64,18,1,11,NA,"pregabalin"
"13",21,"M. Tanabe","Gabapentin and pregabalin ameliorate mechanical hypersensitivity after spinal cord injury in mice",2009,"European Journal of Pharmacology",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=64549120118&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=64549120118&origin=inward",7,"2021-01-15 16:55:13","Article","10.1016/j.ejphar.2009.03.020","0014-2999","https://api.elsevier.com/content/abstract/scopus_id/64549120118",609,1,65,68,21,1.75,21,1,12,NA,"pregabalin"
"14",22,"F.M. Warner","Early Administration of Gabapentinoids Improves Motor Recovery after Human Spinal Cord Injury",2017,"Cell Reports",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85013158111&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85013158111&origin=inward",6,"2021-01-15 16:55:13","Article","10.1016/j.celrep.2017.01.048","2211-1247","https://api.elsevier.com/content/abstract/scopus_id/85013158111",18,7,1614,1618,22,5.5,22,1,4,NA,"pregabalin"
"15",32,"M. Markandaya","Acute treatment options for spinal cord injury",2012,"Current Treatment Options in Neurology",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84861094043&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84861094043&origin=inward",5,"2021-01-15 16:55:13","Article","10.1007/s11940-011-0162-5","1092-8480","https://api.elsevier.com/content/abstract/scopus_id/84861094043",14,2,175,187,32,3.56,32,1,9,NA,"pregabalin"
"16",42,"K.Y. Ha","Pregabalin as a neuroprotector after spinal cord injury in rats",2008,"European Spine Journal",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=45449084807&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=45449084807&origin=inward",4,"2021-01-15 16:55:13","Article","10.1007/s00586-008-0653-6","0940-6719","https://api.elsevier.com/content/abstract/scopus_id/45449084807",17,6,864,872,42,3.23,42,1,13,NA,"pregabalin"
"17",59,"I. Moreno-Duarte","Targeted therapies using electrical and magnetic neural stimulation for the treatment of chronic pain in spinal cord injury",2014,"NeuroImage",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84889682444&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84889682444&origin=inward",3,"2021-01-15 16:55:13","Review","10.1016/j.neuroimage.2013.05.097","1053-8119","https://api.elsevier.com/content/abstract/scopus_id/84889682444",85,NA,1003,1013,59,8.43,59,1,7,NA,"pregabalin"
"18",67,"A. Rabchevsky","Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward?",2011,"Pharmacology and Therapeutics",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79960570561&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=79960570561&origin=inward",2,"2021-01-15 16:55:13","Review","10.1016/j.pharmthera.2011.05.001","0163-7258","https://api.elsevier.com/content/abstract/scopus_id/79960570561",132,1,15,29,67,6.7,67,1,10,NA,"pregabalin"
"19",101,"H. Hayes","Daily intermittent hypoxia enhances walking after chronic spinal cord injury A randomized trial",2014,"Neurology",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84891871137&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84891871137&origin=inward",1,"2021-01-15 16:55:13","Article","10.1212/01.WNL.0000437416.34298.43","0028-3878","https://api.elsevier.com/content/abstract/scopus_id/84891871137",82,2,104,113,101,14.43,101,1,7,NA,"pregabalin"
